Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)
Sponsor: Hamad Medical Corporation
Terminated
Lack of funding.
Other terminated trials from Hamad Medical Corporation
- Diabetes Mellitus · Jun 2023
- Critical Illness · Phase PHASE2/PHASE3 · Nov 2021
- Perinatal Anxiety · Phase NA · Oct 2021
- Infertility · Jul 2020
- Skeletal Dysplasia · Jul 2020
More terminations from Hamad Medical Corporation
Other Diabetes Mellitus trials with similar outcome
A observational or N/A phase clinical study on Diabetes Mellitus and Type 2 Diabetes Mellitus, this trial is terminated or withdrawn. The trial is conducted by Hamad Medical Corporation and has accumulated 12 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 7 earlier versions
-
Aug 2020 — Nov 2020 [monthly]
Terminated
Status: Suspended → Terminated
-
May 2019 — Aug 2020 [monthly]
Suspended
-
Jun 2018 — May 2019 [monthly]
Suspended
-
May 2018 — Jun 2018 [monthly]
Suspended
-
Apr 2018 — May 2018 [monthly]
Suspended
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Suspended NA
-
Jan 2017 — Aug 2017 [monthly]
Suspended NA
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hamad Medical Corporation
- Weill Cornell Medical College in Qatar
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .